Viewing Study NCT05503550


Ignite Creation Date: 2025-12-24 @ 4:50 PM
Ignite Modification Date: 2025-12-29 @ 8:53 PM
Study NCT ID: NCT05503550
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2025-12-16
First Post: 2022-08-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pre-Approval Access Single Patient Request for Talquetamab in Relapsed or Refractory Multiple Myeloma
Sponsor: Janssen Research & Development, LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module